These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23960836)

  • 1. Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kinetics.
    Bose A; Wong TW; Singh N
    Saudi Pharm J; 2013 Apr; 21(2):201-13. PubMed ID: 23960836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of drug (metoprolol succinate) release by inclusion of hydrophobic polymer in hydrophilic matrix.
    Siddique S; Bose A; Khanam J
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1016-25. PubMed ID: 21401340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Development and Optimization of S (-) Atenolol Floating Sustained Release Matrix Tablets Using Surface Response Methodology.
    Gunjal PT; Shinde MB; Gharge VS; Pimple SV; Gurjar MK; Shah MN
    Indian J Pharm Sci; 2015; 77(5):563-72. PubMed ID: 26798171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and optimization of sustained release matrix tablet of metformin HCl 500 mg using response surface methodology.
    Mandal U; Gowda V; Ghosh A; Selvan S; Solomon S; Pal TK
    Yakugaku Zasshi; 2007 Aug; 127(8):1281-90. PubMed ID: 17666882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
    Kasliwal N; Negi JS; Jugran V; Jain R
    Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
    Wang MY; Yang YP; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical Design and Optimization of Sustained Release Formulations of Pravastatin.
    Gunda RK; Manchineni PR
    Turk J Pharm Sci; 2020 Apr; 17(2):221-227. PubMed ID: 32454783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and in vitro studies of a fixed-dose combination of a bilayer matrix tablet containing metformin HCl as sustained release and glipizide as immediate release.
    Mandal U; Pal TK
    Drug Dev Ind Pharm; 2008 Mar; 34(3):305-13. PubMed ID: 18363146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
    Chandran S; Ravi P; Saha RN
    Yakugaku Zasshi; 2006 Jul; 126(7):505-14. PubMed ID: 16819273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and Evaluation of Cephalexin Extended-release Matrix Tablets Using Hydroxy Propyl Methyl Cellulose as Rate-controlling Polymer.
    Vijay J; Sahadevan J; Prabhakaran R; Gilhotra RM
    J Young Pharm; 2012 Jan; 4(1):3-12. PubMed ID: 22523453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halloysite nanotubes-cellulose ether based biocomposite matrix, a potential sustained release system for BCS class I drug verapamil hydrochloride: Compression characterization, in-vitro release kinetics, and in-vivo mechanistic physiologically based pharmacokinetic modeling studies.
    Husain T; Shoaib MH; Ahmed FR; Yousuf RI; Siddiqui F; Saleem MT; Farooqi S; Jabeen S
    Int J Biol Macromol; 2023 Nov; 251():126409. PubMed ID: 37598820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach.
    Chudiwal VS; Shahi S; Chudiwal S
    Drug Dev Ind Pharm; 2018 May; 44(5):787-799. PubMed ID: 29198152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro Evaluation of the Effect of Combination of Hydrophilic and Hydrophobic Polymers on Controlled Release Zidovudine Matrix Tablets.
    Ganesh S; Radhakrishnan M; Ravi M; Prasannakumar B; Kalyani J
    Indian J Pharm Sci; 2008; 70(4):461-5. PubMed ID: 20046771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Use of Polyvinyl Acetate-Polyvinylpyrrolidone Mixture for the Development of Atenolol Sustained Release Matrix Tablets: Optimization of Formulation through in Vitro-in Vivo Assessment Study.
    Owayez AS; Abd El-Ghany GM; Abu Hashim II
    Chem Pharm Bull (Tokyo); 2017; 65(6):545-557. PubMed ID: 28566647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
    Boyapally H; Nukala RK; Douroumis D
    Drug Deliv; 2009 Feb; 16(2):67-74. PubMed ID: 19267297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Carboxymethyl-Xyloglucan-Based Tramadol Matrix Tablets Using Simplex Centroid Mixture Design.
    Madgulkar AR; Bhalekar MR; Padalkar RR; Shaikh MY
    J Pharm (Cairo); 2013; 2013():396468. PubMed ID: 26555977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.